
Détail de l'auteur
Auteur T. GROSHKOVA |
Documents disponibles écrits par cet auteur (15)

![]()
Article : Périodique
S. BYFORD ; B. BARRETT ; N. METREBIAN ; T. GROSHKOVA ; M. CARY ; V. CHARLES ; N. LINTZERIS ; J. STRANG |Background: Despite evidence of the effectiveness of injectable opioid treatment compared with oral methadone for chronic heroin addiction, the additional cost of injectable treatment is considerable, and cost-effectiveness uncertain. Aims: To[...]![]()
Rapport
OEDT = EMCDDA ; T. FREEMAN ; T. GROSHKOVA ; A. CUNNINGHAM ; P. GRIFFITHS ; D. POTTER ; S. CRAFT ; A. ENGLUND ; M. LYNSKEY ; R. SEDEFOV | Lisbon : OEDT / EMCDDA | EMCDDA Papers, ISSN 2315-1463 | 2019ENGLISH: This paper provides an overview of established and emerging cannabis products in Europe. For each type of product, major issues in its production, distribution, use and effects on health are detailed. In doing so, the paper seeks to in[...]![]()
Article : Périodique
T. GROSHKOVA ; A. CUNNINGHAM ; L. ROYUELA ; N. SINGLETON ; T. SAGGERS ; R. SEDEFOV |Background: The importance of illicit drug price data and making appropriate adjustments for purity has been repeatedly highlighted for understanding illicit drug markets. The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) has [...]Nouveauté
![]()
Rapport
OEDT = EMCDDA ; L. LANIEL ; R. KASECKER ; T. GROSHKOVA ; C. CARPENTIER | Lisbon : OEDT / EMCDDA | EMCDDA Papers, ISSN 2315-1463 | 2013Drug law enforcement activity targets the supply of drugs and is responsible for much of the key data that informs our understanding of drugs supply in Europe. This study looks, for the first time, at how drug law enforcement is organised in Eur[...]![]()
Article : Périodique
Interventions to tackle the supply of drugs are seen as standard components of illicit drug policies. Therefore drug market-related administrative data, such as seizures, price, purity and drug-related offending, are used in most countries for p[...]Nouveauté
![]()
Rapport
OEDT = EMCDDA ; J. MOUNTENEY ; T. GROSHKOVA ; D. THANKI ; A. CUNNINGHAM ; M. RYCHERT | Lisbon : OEDT / EMCDDA | EMCDDA Papers, ISSN 2315-1463 | 2014Concerns about the availability and use of methamphetamine in Europe have been growing for some time. Historically, the use of methamphetamine has been confined largely to the Czech Republic and Slovakia; however, recent signs of the spread of m[...]![]()
Article : Périodique
J. STRANG ; T. GROSHKOVA ; A. UCHTENHAGEN ; W. VAN DEN BRINK ; C. HAASEN ; M. T. SCHECHTER ; N. LINTZERIS ; J. BELL ; A. PIRONA ; E. OVIEDO-JOEKES ; R. SIMON ; N. METREBIAN |BACKGROUND: Supervised injectable heroin (SIH) treatment has emerged over the past 15 years as an intensive treatment for entrenched heroin users who have not responded to standard treatments such as oral methadone maintenance treatment (MMT) or[...]![]()
Rapport
OEDT = EMCDDA ; J. MOUNTENEY ; M. RUIZ ; A. BO ; T. GROSHKOVA ; J. MATIAS ; L. VANDAM ; F. CARDOSO ; R. CHRISTIE ; L. MONTANARI ; I. GIRAUDON ; P. GRIFFITHS | Lisbon : OEDT / EMCDDA | Rapid communication | 2017This report provides a first look at the emergence of more problematic forms of use of new psychoactive substances among a range of demographic groups, including opioid and amphetamine injectors, prisoners, the homeless and men who have sex with[...]![]()
Article : Périodique
ENGLISH: AIMS: To quantify changes in (i) potency (concentration of Delta9-tetrahydrocannabinol; %THC), (ii) price (euros/g of cannabis) and (iii) value (mg THC/euro) of cannabis resin and herbal cannabis in Europe. DESIGN: Repeated cross-sect[...]![]()
Rapport
The prescription of substitution drugs, such as methadone and buprenorphine, has become a mainstream, first-line treatment for opioid dependence, with around 700 000 of Europe's 1.3 million problem opioid users receiving substitution treatment t[...]![]()
Rapport
OEDT = EMCDDA ; T. GROSHKOVA ; D. HEDRICH ; M. FERRI ; L. MONTANARI | Lisbon : OEDT / EMCDDA | EMCDDA Papers, ISSN 2315-1463 | 2014Today, in most European countries, residential treatment programmes form an important element of the range of treatment and rehabilitation options for drug users. The aim of this paper is to provide a Europe-wide overview of the history and avai[...]![]()
Article : Périodique
J. STRANG ; N. METREBIAN ; N. LINTZERIS ; L. POTTS ; T. CARNWATH ; S. MAYET ; H. WILLIAMS ; D. ZADOR ; R. EVERS ; T. GROSHKOVA ; V. CHARLES ; A. MARTIN ; L. FORZISI |Background: Some heroin addicts persistently fail to benefit from conventional treatments. We aimed to compare the effectiveness of supervised injectable treatment with medicinal heroin (diamorphine or diacetylmorphine) or supervised injectable [...]![]()
Article : Périodique
V. LORENZETTI ; C. HINDOCHA ; K. PETRILLI ; P. GRIFFITHS ; J. BROWN ; A. CASTILLO-CARNIGLIA ; J. P. CAULKINS ; A. ENGLUND ; M. A. ElSOHLY ; S. H. GAGE ; T. GROSHKOVA ; A. GUAL ; D. HAMMOND ; W. LAWN ; H. LOPEZ-PELAYO ; J. MANTHEY ; C. MOKRYSZ ; R. L. PACULA ; M. VAN LAAR ; R. VANDREY ; E. WADSWORTH ; A. WINSTOCK ; W. HALL ; H. V. CURRAN ; T. P. FREEMAN |BACKGROUND: The lack of an agreed international minimum approach to measuring cannabis use hinders the integration of multidisciplinary evidence on the psychosocial, neurocognitive, clinical and public health consequences of cannabis use. METH[...]![]()
Rapport
OEDT = EMCDDA ; T. GROSHKOVA ; A. CUNNINGHAM ; N. SINGLETON ; T. STOIAN ; R. SEDEFOV | Lisbon : OEDT / EMCDDA | EMCDDA Papers, ISSN 2315-1463 | 2019This paper describes open-source information monitoring and how we use it at the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) in the area of drug markets - what it is and, importantly, what it is not; the methodology for its [...]![]()
Article : Périodique
T. GROSHKOVA ; T. STOIAN ; A. CUNNINGHAM ; P. GRIFFITHS ; N. SINGLETON ; R. SEDEFOV |The COVID-19 pandemic and the response to have resulted in an increase in sales activity levels on darknet markets during the first 3 months of 2020, mainly related to cannabis products. One key question is whether more people will become used t[...]